Vivos Therapeutics (VVOS) Short Interest Ratio & Short Volume $2.08 -0.06 (-2.80%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.10 +0.02 (+0.72%) As of 05/21/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vivos Therapeutics Short Interest DataVivos Therapeutics (VVOS) has a short interest of 259,400 shares, representing 5.65% of the float (the number of shares available for trading by the public). This marks a 17.59% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 454,040 shares to cover all short positions.Current Short Interest259,400 sharesPrevious Short Interest220,600 sharesChange Vs. Previous Month+17.59%Dollar Volume Sold Short$736,696.00Short Interest Ratio2.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares5,890,000 sharesFloat Size4,590,000 sharesShort Percent of Float5.65%Today's Trading Volume88,840 sharesAverage Trading Volume454,040 sharesToday's Volume Vs. Average20% Short Selling Vivos Therapeutics? Sign up to receive the latest short interest report for Vivos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVVOS Short Interest Over TimeVVOS Days to Cover Over TimeVVOS Percentage of Float Shorted Over Time Vivos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025259,400 shares $736,696.00 +17.6%5.7%2.3 $2.84 4/15/2025220,600 shares $483,114.00 -23.3%4.8%1.7 $2.19 3/31/2025287,700 shares $819,945.00 +15.5%6.3%1.6 $2.85 3/15/2025249,000 shares $821,700.00 -27.6%5.4%1.2 $3.30 2/28/2025344,000 shares $1.19 million +22.1%7.5%1.5 $3.47 2/15/2025281,700 shares $1.13 million +0.1%6.1%1.1 $4.00 1/31/2025281,400 shares $1.12 million +3.1%6.1%1.1 $3.97 1/15/2025273,000 shares $1.40 million +134.9%6.3%1.1 $5.12 12/31/2024116,200 shares $498,498.00 -21.5%2.7%0.6 $4.29 12/15/2024148,000 shares $682,280.00 +28.9%3.9%0.7 $4.61 Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024114,800 shares $391,468.00 -12.2%2.7%0.1 $3.41 11/15/2024130,800 shares $371,472.00 +37.5%3.0%0.1 $2.84 10/31/202495,100 shares $239,652.00 +36.3%2.2%0.1 $2.52 10/15/202469,800 shares $172,406.00 -25.4%1.6%0.1 $2.47 9/30/202493,600 shares $244,296.00 +46.9%2.3%0.1 $2.61 9/15/202463,700 shares $187,915.00 +12.0%2.0%0 $2.95 8/31/202456,900 shares $154,199.00 -34.9%1.8%0.9 $2.71 8/15/202487,400 shares $194,902.00 +54.7%2.7%1.4 $2.23 7/31/202456,500 shares $129,950.00 -3.9%1.8%0.9 $2.30 7/15/202458,800 shares $164,052.00 -40.1%1.8%0.9 $2.79 6/30/202498,100 shares $217,782.00 +92.0%3.1%0.7 $2.22 6/15/202451,100 shares $114,975.00 +5.6%1.6%0.3 $2.25 5/31/202448,400 shares $101,156.00 +4.3%1.6%0.3 $2.09 5/15/202446,400 shares $101,152.00 -26.1%1.6%0.3 $2.18 4/30/202462,800 shares $158,884.00 -67.1%2.3%0.3 $2.53 4/15/2024191,100 shares $529,347.00 +921.9%7.6%0.9 $2.77 3/31/202418,700 shares $90,321.00 -28.6%0.8%0.1 $4.83 3/15/202426,200 shares $117,900.00 +11.0%2.3%0.2 $4.50 2/29/202423,600 shares $137,116.00 -19.2%2.1%0.1 $5.81 2/15/202429,200 shares $156,512.00 -38.1%2.6%0 $5.36 1/31/202447,200 shares $347,864.00 +237.1%4.2%0 $7.37 1/15/202414,000 shares $111,300.00 -84.0%1.2%0 $7.95 12/31/202387,300 shares $1.09 million -46.2%N/A0 $12.44 12/15/2023162,300 shares $1.49 million +512.5%14.6%0.1 $9.21 11/30/202326,500 shares $649,250.00 -31.2%2.4%0 $24.50 11/15/202338,500 shares $148,225.00 +13.2%3.9%0.2 $3.85 10/31/202334,000 shares $109,140.00 -98.5%3.4%0.2 $3.21 10/15/20232,270,000 shares $732,302.00 +297.1%N/A0.4 $0.32 9/30/2023571,600 shares $109,804.36 +8.3%N/A0.1 $0.19 9/15/2023527,700 shares $129,286.50 -18.9%N/A0.3 $0.25Banks aren’t ready for this altcoin—are you? (Ad)Bitcoin Just Made Headlines — Here’s Where I’m Putting My Money Next There's a little-known crypto project sitting right in the sweet spot of all these trends and based on what I'm seeing — it could run even harder than BTC.Grab the full details here before the rest of the market wakes up 8/31/2023650,300 shares $163,420.39 -43.0%N/A0.4 $0.25 8/15/20231,140,000 shares $372,096.00 +1,388.3%N/A0.7 $0.33 7/31/202376,600 shares $22,290.60 -33.6%N/A0.1 $0.29 7/15/2023115,300 shares $36,492.45 +63.3%N/A0.5 $0.32 6/30/202370,600 shares $36,006.00 -69.7%N/A0.5 $0.51 6/15/2023232,900 shares $128,421.06 -5.2%N/A1.4 $0.55 5/31/2023245,600 shares $93,720.96 +11.5%N/A1.3 $0.38 5/15/2023220,200 shares $72,666.00 +48.1%N/A0.3 $0.33 4/30/2023148,700 shares $51,152.80 -21.9%N/A0.2 $0.34 4/15/2023190,400 shares $63,574.56 +31.7%N/A0.3 $0.33 3/31/2023144,600 shares $49,323.06 -45.1%N/A0.2 $0.34 3/15/2023263,500 shares $96,599.10 +449.0%1.3%0.1 $0.37 2/28/202348,000 shares $29,280.00 -82.9%0.2%0 $0.61 2/15/2023281,000 shares $256,384.40 -5.9%1.4%0.1 $0.91 1/31/2023298,700 shares $325,583.00 -65.5%1.7%0.1 $1.09 1/15/2023865,100 shares $1.51 million +576.4%4.8%0.4 $1.75 12/30/2022127,900 shares $51,415.80 +10.6%0.7%0.1 $0.40 12/15/2022115,600 shares $40,286.60 -16.4%0.6%1.6 $0.35 11/30/2022138,200 shares $69,100.00 -17.8%0.8%3.5 $0.50 11/15/2022168,200 shares $115,368.38 -22.8%0.9%4.9 $0.69 10/31/2022217,900 shares $156,888.00 +29.0%1.2%5.2 $0.72 10/15/2022168,900 shares $116,000.52 -0.2%0.9%4 $0.69 9/30/2022169,300 shares $110,028.07 +19.1%0.9%4.2 $0.65 9/15/2022142,100 shares $161,994.00 -20.9%0.8%3.8 $1.14 8/31/2022179,600 shares $220,908.00 +26.5%1.0%4.3 $1.23 8/15/2022142,000 shares $200,220.00 -43.6%0.8%3 $1.41 7/31/2022251,600 shares $289,340.00 +19.9%1.4%5.3 $1.15 7/15/2022209,800 shares $295,818.00 -17.4%1.2%3.9 $1.41 6/30/2022254,100 shares $327,789.00 -3.6%1.5%4.3 $1.29 6/15/2022263,500 shares $337,280.00 -32.5%1.5%3.5 $1.28 5/31/2022390,500 shares $792,715.00 -4.9%2.3%4.9 $2.03 5/15/2022410,700 shares $570,873.00 +50.6%2.4%3.5 $1.39 4/30/2022272,800 shares $471,944.00 -32.2%1.6%1.9 $1.73 4/15/2022402,300 shares $788,508.00 -16.8%2.3%0.8 $1.96 3/31/2022483,600 shares $1.30 million -5.7%2.8%0.2 $2.68 3/15/2022512,900 shares $1.38 million -31.4%3.0%0.2 $2.69 2/28/2022747,700 shares $2.50 million +54.3%4.3%0.4 $3.34 2/15/2022484,700 shares $1.17 million -60.6%2.8%0.2 $2.42 1/31/20221,230,000 shares $3.04 million +760.1%7.1%0.6 $2.47 1/15/2022143,000 shares $267,410.00 -10.8%1.0%0.1 $1.87 12/31/2021160,300 shares $360,675.00 -15.8%1.2%1.2 $2.25 12/15/2021190,400 shares $531,216.00 -36.6%1.4%1.3 $2.79 11/30/2021300,300 shares $765,765.00 -19.0%2.2%1.4 $2.55 11/15/2021370,800 shares $1.51 million -11.6%2.7%1.1 $4.06 10/29/2021419,400 shares $1.52 million +41.6%3.1%0.1 $3.63 10/15/2021296,200 shares $1.05 million +3.6%2.2%0.1 $3.55 9/30/2021285,800 shares $1.15 million -0.1%2.1%0.1 $4.04 9/15/2021286,200 shares $1.35 million -56.2%2.1%0.1 $4.73 8/31/2021652,700 shares $3.43 million +1,390.2%4.8%0.2 $5.26 8/13/202143,800 shares $143,226.00 -25.8%0.3%0 $3.27Banks aren’t ready for this altcoin—are you? (Ad)Bitcoin Just Made Headlines — Here’s Where I’m Putting My Money Next There's a little-known crypto project sitting right in the sweet spot of all these trends and based on what I'm seeing — it could run even harder than BTC.Grab the full details here before the rest of the market wakes up 7/30/202159,000 shares $178,180.00 -50.7%0.4%0.2 $3.02 7/15/2021119,700 shares $514,710.00 +193.4%0.9%0.4 $4.30 6/30/202140,800 shares $201,960.00 -17.7%0.3%0.1 $4.95 6/15/202149,600 shares $288,176.00 -22.0%0.4%0.3 $5.81 5/28/202163,600 shares $342,168.00 +1.0%0.5%0.3 $5.38 5/14/202163,000 shares $372,960.00 +90.3%0.5%0.4 $5.92 4/30/202133,100 shares $223,425.00 -45.7%0.3%0.2 $6.75 4/15/202160,900 shares $542,010.00 +45.4%0.6%0.3 $8.90 3/31/202141,900 shares $283,663.00 +165.2%0.4%0.2 $6.77 3/15/202115,800 shares $117,552.00 -31.9%0.2%0.1 $7.44 2/26/202123,200 shares $174,928.00 -33.9%0.2%0 $7.54 2/12/202135,100 shares $245,349.00 +317.9%0.3%0.1 $6.99 1/29/20218,400 shares $56,658.00 -88.0%0.1%0 $6.75 1/15/202170,100 shares $560,099.00 No Change0.6%0.1 $7.99 VVOS Short Interest - Frequently Asked Questions What is Vivos Therapeutics' current short interest? Short interest is the volume of Vivos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 259,400 shares of VVOS short. 5.65% of Vivos Therapeutics' shares are currently sold short. Learn More on Vivos Therapeutics' current short interest. What is a good short interest ratio for Vivos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VVOS shares currently have a short interest ratio of 2.0. Learn More on Vivos Therapeutics's short interest ratio. What is a good short interest percentage for Vivos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.65% of Vivos Therapeutics' floating shares are currently sold short. Is Vivos Therapeutics' short interest increasing or decreasing? Vivos Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 259,400 shares, an increase of 17.6% from the previous total of 220,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vivos Therapeutics' float size? Vivos Therapeutics currently has issued a total of 5,890,000 shares. Some of Vivos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vivos Therapeutics currently has a public float of 4,590,000 shares. How does Vivos Therapeutics' short interest compare to its competitors? 5.65% of Vivos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Vivos Therapeutics: Inovio Pharmaceuticals, Inc. (17.74%), Nutriband Inc. (3.80%), Zynex, Inc. (21.28%), Vivani Medical, Inc. (1.06%), Outset Medical, Inc. (32.00%), Hyperfine, Inc. (2.40%), SurgePays, Inc. (3.69%), Cytosorbents Co. (2.41%), IceCure Medical Ltd (0.83%), Apyx Medical Co. (0.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Vivos Therapeutics stock? Short selling VVOS is an investing strategy that aims to generate trading profit from Vivos Therapeutics as its price is falling. VVOS shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vivos Therapeutics? A short squeeze for Vivos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VVOS, which in turn drives the price of the stock up even further. How often is Vivos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVOS, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies INO Short Interest NTRB Short Interest ZYXI Short Interest VANI Short Interest OM Short Interest HYPR Short Interest SURG Short Interest CTSO Short Interest ICCM Short Interest APYX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VVOS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VVOS Stock Free VVOS Stock Alerts